Just a moment, the page is loading... Browse ALL STUDIES Keyword Search View All Selected Clear All Login / Create Account

• Login
• Create Account

• Home
• About Us
  • Privacy Policy
  • Minimum System Requirements
  • How To Join
• Mission
• Data Sponsors
• Researchers
• How It Works
  • How to Request Data
  • Review of Requests
  • Data Sharing Agreement
  • Access to Data
• Independent Review Panel
• Metrics
• FAQs
• News
• Help/Contact Us

TAKEDA-C02-021

Study Sponsor : Takeda

Study TitleA Phase 3, Open-Label, Randomized, Allopurinol-Controlled Study to Assess the Long-Term Safety of Oral Febuxostat in Subjects With Gout

Medicine or Vaccine (generic name) febuxostat

Sponsor Identification Number C02-021

Trial Registry Identification Number(#'s) NCT00175019

Medical ConditionHyperuricemia

PhasePhase 3

Link to study details on the Takeda Clinical Study Registerhttp://takedaclinicaltrials.com/browse/summary/C02-021

Link to study details on ClinicalTrials.gov (if available)https://clinicaltrials.gov/show/NCT00175019

Link to study details on EudraCT (if available)Not available

Datasets and Documents Available for this Study Raw dataset Annotated case report form Dataset specifications Protocol with any amendments Analysis-ready dataset Reporting and analysis plan Clinical study report Ready to Share

Additional information about the data and documents available for this studyAnnotated case report forms are N/A. Blank case report forms will be provided.

Date Added to this SiteApril 2015

• © 2025 ideaPoint. All Rights Reserved.
• Powered by ideaPoint.
• Help
• Privacy Policy
• Cookie Policy
• Help and Resources